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ABSTRACT
Introduction: Malaria during pregnancy remains a serious public health problem. The aim 
of this study was to establish the prevalence and possible risk factors for malaria in pregnant 
women attending antenatal care at Augusto Ngangula Specialized General Hospital in 
Luanda, Angola. Methods: Pregnant women (679 total) who attended antenatal care from 
April to September 2008 were included in the study after signing informed consent. For each 
participant, the social-demographic profile and malaria and obstetric histories were investigated 
via a questionnaire. Diagnosis was made by optic microscopy, and hemoglobin concentration 
measured. The associations between age, parity, gestational age, residence, schooling, malaria 
during gravity, anemia and treatment with incidence of Plasmodium falciparum infection were 
analyzed through logistic regression. Results: During the period of study, 74 (10.9%) out of 
679 women were infected by P. falciparum. The average concentration of hemoglobin was 11.1 
± 0.07g/dL, and there were significant associations between the history of malaria during 
pregnancy, P. falciparum infection (p<0.01) and anemia at the time of observation (p<0.001). 
Conclusions: Previous history of malaria during pregnancy represents a risk factor for current 
infection and anemia was an important complication associated with malaria, even in women 
who were treated with sulfadoxine-pyrimethamine during pregnancy.
Keywords: Malaria. Pregnancy. Africa. Prevalence. Stable transmission.
RESUMO
Introdução: A malária na gravidez continua a ser um grave problema de saúde pública. O 
objetivo deste estudo foi determinar a prevalência e possíveis fatores de risco para a malária, em 
mulheres grávidas que foram atendidas em consultas pré-natal, no Hospital Geral Especializado 
Augusto Ngangula, em Luanda, Angola. Métodos: De abril a setembro de 2008, 679 mulheres 
grávidas foram envolvidas no estudo após consentimento informado. O perfil sócio demográfico 
e história de malária e obstetrícia foram investigados através de um questionário. O diagnóstico 
foi efetuado por microscopia óptica e determinou-se ainda as concentrações da hemoglobina. 
Através da regressão logística foi analisada a associação entre a idade, paridade, tempo de 
gestação, residência, escolaridade, malária durante a gravidez, anemia e tratamento com a 
infecção por Plasmodium falciparum. Resultados: Setenta e quatro (10,9%) das 679 mulheres 
estavam infectadas com P. falciparum. O valor médio da concentração da hemoglobina foi de 
11,1 ± 0,07g/dL, encontrando-se uma associação significativa entre história de malária na 
gravidez e infecção por P. falciparum (p<0,01) e anemia no momento da observação (p<0.001). 
Conclusões: A história de malária anterior na gravidez foi um fator de risco para uma infecção 
atual e a anemia uma complicação importante associada à malária, mesmo em mulheres que 
receberam tratamento durante a gravidez com sulfadoxina-pirimetamina.
Palavras-chaves: Malária. Gravidez. África. Prevalência. Transmissão estável.
Malaria from Plasmodium falciparum during 
pregnancy is a serious public health problem in 
Sub-Saharan Africa. More than 50 million women 
residing in malaria-endemic areas become pregnant 
every year1-3. Although malaria during pregnancy 
might be asymptomatic due to the development of 
some degree of immunity by mothers residing in 
areas with stable transmission, it is still associated 
with unfavorable effects on the mother or the child4-8. 
For this reason, abortions, stillbirths, premature 
deliveries and maternal deaths are common 
phenomena9,10. Many, if not most, cases of maternal 
and perinatal death can be prevented11.
The impact of malaria-related anemia on 
pregnant women (id est., the risk of death) and 
fetuses (i.e., low birthweight) has been increasingly 
acknowledged during the last decades12,13, keeping 
in mind that anemia does not necessarily have to 
be symptomatic to become a risk factor during 
pregnancy. Low birth weight in newborns from 
mothers who had malaria during pregnancy 
is common; it is estimated that it causes 5% of 
perinatal deaths in areas with poor resources14. The 
prevalence of infection and the density of parasites 
reach their peak during the first half of pregnancy 
and progressively decrease until delivery15.
Factors that influence the prevalence of malaria 
in pregnant women were identified and include 
maternal age, parity, use of prophylaxis, nutrition, 
genetics of the host, level of anti-parasitic immunity 
and genetics of the parasite16.
During the last decade, several studies were 
performed in African countries with high indices of 
transmission17-24; however, few data were published 
for Angola, which is one of the five countries with the 
lowest available amounts of information regarding 
malaria during pregnancy, a fact that makes decision-
making for prevention and control difficult25. The aim of 
this study was to assess the prevalence of  P.  falciparum 
and its possible associated risk factors in pregnant 
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Setting of the study and participants
A transversal study was performed at the antenatal care (ANC) 
facility at Augusto Ngangula Specialized General Hospital (Hospital 
Geral Especializado Augusto Ngangula - HGEAN) in Luanda, 
Angola. The study was performed during the high-transmission 
season, from April to September 2008. Pregnant women were 
recruited during routine antenatal visits. All patients were invited to 
participate in the study. Only those who gave informed consent were 
included; women with other diseases, particularly HIV carriers, were 
excluded. Each participant was evaluated only once. 
Data collection
Data on malaria in pregnant women who attended ANC at 
HGEAN were obtained via a questionnaire including the following 
information: social-demographic profile, malaria history and obstetric 
history, including age, parity, gestational age and place of residence. 
Gestational age was calculated from the last menstruation date and via 
ultrasound when there was uncertainty. The obstetric physical exam 
helped to complete the required data (blood pressure, paleness of 
conjunctiva, level of the uterine fundus and fetal heart rate).
Blood collection and microscopic diagnosis
Blood was collected through digital or venous puncture. Samples 
were prepared for parasite detection and estimation of parasitemia. 
Blood smear and thick drop assays were prepared according to the 
protocol described by the World Health Organization (WHO)26. 
Blood smear and thick drop assays were stained with 10% Giemsa 
dye. Smears were fixed with methanol for one minute before staining. 
Parasite density was assessed by counting parasites in 200 leukocytes, 
assuming that each woman had 8,000 leukocytes/μL of blood. Smears 
were rated negative when there were no parasites in 200 fields of a 
thick drop smear in immersion oil27.
Hemoglobin determination
Hemoglobin concentrations were determined by the hematic 
acid method using a hemoglobinometer (HaemoCue, Switzerland) 
in all 679 cases in the study.
Statistical analysis of data
Data were stored in a Windows Microsoft Excel® spreadsheet and 
were revised for verification. The software SPSS v.18.0 for Windows 
(SPSS, Inc.) was used to analyze data.
An exploratory and descriptive analysis of variables (some of 
which were re-codified) was performed. For continuous variables, 
comparisons between two or more independent groups were 
analyzed using Mann-Whitney U and Kruskal-Wallis tests, after the 
failures of the presuppositions of the parametric tests (Student’s 
t-test and ANOVA) were verified. For qualitative variables, the 
Pearson Chi-Square test was used. A value of p<0.05 was considered 
significant. For estimation of the prevalence of P. falciparum infection 
with a 95% confidence interval (CI), the Agresti-Coull, Wilson or 
Jeffreys methods were used, as recommended28. As described below, 
simple and multiple logistic regression models were also used29,30. To 
identify a simpler model, a Backward/Wald procedure was also used 
to automatically discard non-significant variables.
The variable malaria (including with and without P. falciparum 
infection categories) was considered the dependent variable; age, 
parity, gestational age, residence, schooling, (previous) malaria 
during pregnancy and treatment were considered independent 
variables. Variables were categorized as follows: age (≤18 yearsold, 
19-24 yearsold, >24 yearsold); parity [primiparous and multiparous 
(≥2 births)]; gestational age [first trimester (<14 weeks), second 
trimester (14-27 weeks) and third trimester (≥28 weeks)]; 
and treatment during pregnancy [no treatment, sulfadoxine-
pyrimethamine treatment and other drugs]. Hemoglobin 
concentrations were classified as anemia (<11g/dL), severe anemia 
(<7g/dL) and normal (≥11g/dL).
Simple and multiple logistic regressions were used to analyze 
potential risk factors associated with the presence of ongoing P. 
falciparum infection. To investigate the association between the 
several independent variables and malaria, we began by performing 
simple logistic regressions with each independent variable.
Next, we applied multiple regression models to control possible 
confusion. Variables exhibiting statistically significant associations 
(p<0.05) or with important epidemiological meanings were 
included. These co-variables were kept in models, independent of 
their significance, in univariate analysis due to their possible relevance 
in the final results; thus, we could analyze their possible influence 
when considered together with the other variables. The first model 
included the independent variables treatment, age, anemia (with and 
without infection), parity and malaria during pregnancy; the second 
model also included gestational age.
Ethical considerations
This study was approved by the Ethics Committee of the Faculty 
of Medicine of Agostinho Neto University, Luanda, Angola.
Population study
Data were collected from a total of 679 pregnant women who 
attended ANC at HGEAN. The demographic and obstetric profiles 
and the parasitological-hematological data were collected from the 
participants. These profiles are summarized in Table 1. Briefly, the 
ages of the women ranged between 12 and 42 years (mean= 25.7 
years and median= 25 years); most women (66.1%) had a low 
schooling level, most were multiparous (74.1%), and more were in 
the second trimester of pregnancy (46.2%) than were in either the 
first or third trimesters.
Optical microscopy performed at the time of the study showed 
mono-infection by P. falciparum in 10.9% (n=74) of women (n=679), 
with a 95%CI between 8.8% and 13.5%. Distribution according 
to gestational age was as follows: 1st trimester=9.7% (n=18), 
2nd trimester = 11.5% (n=36%), and 3rd trimester = 11.1% (n=20). 
Details on parasitemia and the stratification of parity and gestational 
age are summarized in Table 2. The prevalences of P. falciparum 
(expressed in percentages) in primiparous (11.9%) and multiparous 
(10.5%) women were not significantly different. Additionally, the 
densities of parasites between primiparous and multiparous women 
were not significantly different. The rates of infection according to 
pregnancy trimester (expressed in percentages) were higher in the 
second and third trimesters (though these rates were not statistically 
significant).
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TABLE 1 -Demographic and obstetric profiles of the participants (n=679) 
in the study.





no or basic schooling 449 66.1







Gestational age  
1st trimester (<14 weeks) 185 27.3
2nd trimester (14-27 weeks) 314 46.2
3rd trimester (≥28 weeks) 180 26.5
TABLE 2 - Rate of Plasmodium falciparum prevalence in women who attended the Augusto Ngangula SpecializedGeneral Hospital (HGEAN), according to the 
demographic and obstetric variable categories.
                                                                                                            Pregnant women
 with without % of  
Demographic and obstetric variables infection infection infected P*
Age (years)    0.552
<18  5 43 10.4 
19-24  25 242 9.4 
>24 44 320 12.1 
Parity    0.350
primiparous 31 155 11.9 
multiparous 53 450 10.5 
Education    
no or basic schooling 46 403 10.2 0.270
secondary and higher 28 202 13.8 
Residence    
urban 15 145 9.4 0.292
peri-urban 59 460 11.4 
Gestational age    
1st trimester (<14 weeks) 18 167 9.7 0.830
2nd trimester (14-27 weeks) 36 278 11.5 
3rd trimester (≥28 weeks) 20 160 11.1 
Treatment    
without 50 420 10.6 0.464
sulfadoxine-pyrimethamine 12 109 9.9 
other 11 62 15.1 
don’t know/no answer 1 14 6.7 
Total 74 605 10.9 
*Value of p according to the Pearson Chi-Square test.
The mean and standard deviation of hemoglobin concentration in 
the studied samples was 11.1 ± 0.07g/dL, and the median was 10g/
dL.When comparing the median values of hemoglobin concentration 
between P. falciparum-infected (9.9g/dL) and non-infected (11.1g/dL) 
pregnant women,a highly significant difference was identified 
(p<0.001). It is notable that the values of serum hemoglobin in non-
infected women had a tendency for greater dispersion (Figure 1).
 A significant association (p<0.001) was found between anemia 
(defined as a hemoglobin concentration < 11g/dL) and the presence/
absence of P. falciparum; among the 339 anemic women, 56 (16.5%) 
were infected with P. falciparum, whereas among the 337 non-anemic 
women, only 17 (5%) were infected (Table 3). Only eight (1.2%) 
women fell into the category of severe anemia (< 7g/dL), and none 
had malaria. For this reason, logistic regression recorded some 
numerical instabilities; in later analysis, we only considered categories 
with or without anemia, independent of its severity. We also observed 
that anemia was associated with gestational age and treatment.
When women were classified as primiparous or multiparous, 
both primiparous and multiparous women infected with 
P. falciparum showed a (non-significant) tendency for lower values 
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FIGURE 2 - Concentrations of serum hemoglobin in pregnant women as a 
function of treatment and presence of malaria. Star: possible extreme outliers; 
open circle: possible outliers. 
FIGURE 1 - Concentrations of serum hemoglobin in pregnant women with and 
without malaria. Star: possible extreme outliers; open circle: possible outliers. 
TABLE 3 -Anemia among women as a function of gestational age and treatment.
                 Women 
 without anemia with anemia 
Caracteristics n % n % P*
Gestational age   0.001
1st trimester 114 33.8 70 20.6
2nd trimester 141 41.8 172 50.7
3rd trimester 82 24.3 97 28.6
Treatment   
without 260 78.1 217 64.4 <0.001
sulfadoxine-pyrimethamine 41 12.3 80 23.7
other  32 9.6 40 11.9
*Value of p according to the Pearson Chi-Square test.
of circulating hemoglobin than did women who were not infected 
with P. falciparum.
When comparing the median values of hemoglobin levels and 
types of treatment, significant differences were identified (p<0.001, 
Kruskal-Wallis test). Multiple comparisons showed that hemoglobin 
levels in women treated with sulfadoxine-pyrimethamine differed 
significantly from both untreated women and women treated by other 
means. When classified according to their current state of infection, 
this pattern of differences between treatments was maintained 
in non-infected women (p<0.001) (Figure 2; blue). In infected 
women, there were still significant differences (p=0.023) between 
treatments (Figure 2; green); there were differences in hemoglobin 
concentrations only between sulfadoxine-pyrimethamine-treated 
and untreated women.
When a multiple logistic regression model was applied that 
included the variables treatment, age, anemia, parity, malaria during 
pregnancy and gestational age, only anemia and malaria during 
pregnancy showed significant associations with current malaria.
Infection was significantly more common in women with 
anemia than in those without [Relative risk estimated by odds ratio 
(OR) = 4.03, 95% CI 2.23-7.27].Women who had previous 
malaria during pregnancy also had a higher risk of current malaria 
[OR = 4.86, 95% CI 1.45-16.25].
Finally, when a Backward/Wald-like procedure was used, we 
ended in stage 5, including only anemia and malaria during pregnancy 
in the models, thus strengthening the association of these variables 
with current malaria.
Malaria is an avoidable cause of maternal and fetal mortality 
and morbidity; however, the international community is far from 
implementing the necessary interventions to drastically reduce 
the impact of this disease in the countries where it is endemic. 
Early detection and timely and adequate treatment are essential 
requirements for reducing the incidence of deaths and must be the 
main components of anti-malaria intervention in underdeveloped 
countries6-8. This study sought to characterize the pattern of malaria-
related morbidity during pregnancy at Augusto Ngangula Specialized 
General Hospital in Luanda, Angola, an urban area rated as having 
stable transmission by the Department of Endemics Control. The 
prevalence of malaria during pregnancy was 10.9% (95% CI 8.8%-
13.5%), which agrees with the prevalence in African countries that 
are characterized as having intense transmission of malaria8,17,21. This 
study showed that there was no association between malaria and 
parity, as has also been reported by other studies performed in areas 
with intense transmission of malaria31. In areas where transmission is 
high, the level of acquired immunity is significant, and primiparous 
women are the most affected17,21; however, our study found a larger 
affected number among multiparous women. In this study, the ages 
of infected and non-infected women were not significantly different. 
This agrees with some data published in the literature18; 
however, other studies performed in Sub-Saharan Africa have 
reported a significant association between maternal age and malaria 
during pregnancy17,32. Women who attended antenatal care during 
the second and third trimesters of pregnancy exhibited higher 
prevalences of malaria infection. This agrees with several studies that 
have reported the second trimester, along with the beginning of the 






























third trimester, as the peak of prevalence15,19,21,33,34. However, other 
studies have named the first trimester as the major risk period21. Our 
limitation resides in the fact that in high transmission areas, many 
P. falciparum infections during pregnancy stay undetected when 
only microscopy of Giemsa-stained blood smears of peripheral 
blood is used for diagnosis. These sub-microscopic infections can 
only be diagnosed by detection of circulating parasitic antigens or 
detection of parasite-specific DNA using conventional polymerase 
chain reaction (PCR), nested PCR, or the more recently developed 
real-time PCR5,35-37.
Currently intermittent presumptive treatment in pregnancy is 
recommended by the WHO for areas of high malaria transmission. 
Sulfadoxine-pyrimethamine has been reported as the drug of choice, 
for its effectiveness to eliminate completely P. falciparum infections 
and therefore prevent adverse birth outcome caused by sub-
microscopic parasitemia, including anemia and low birth weight38. 
The average concentration of hemoglobin was significantly lower 
in infected women as described previously for malaria12,13. 
Additionally, in this study, women who reported having used 
sulfadoxine-pyrimethamine had lower concentrations of hemoglobin 
than women who used other treatments, a fact that might suggest 
that soon, these drugs will no longer be efficacious. However, the 
results of a recent study performed in Luanda showed the presence 
(still relatively low) of markers of resistance (9%) to sulfadoxine-
pyrimethamine compared to chloroquine resistance markers39. In 
spite of this, in some areas of Angola (Huambo and Bié), resistance 
to sulfadoxine-pyrimethamine has reached 25%40. Thus, the efficacy 
of treatment with these drugs must be evaluated and monitored, as 
should the preventive intermittent treatment (PIT) that a recent 
study performed in Ghana showed was still efficient for reducing 
the levels of anemia associated with malaria41.
Our results suggest that P. falciparum is common in pregnant 
women attending antenatal care in Luanda and that anemia is an 
important complication associated with P. falciparum infection. The 
second trimester of pregnancy seems to represent the peak of highest 
risk, a fact that might support decision-making concerning PIT with 
sulfadoxine-pyrimethamine and the use of anti-mosquito nets, as is 
currently recommended in Angola.
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